Minute Insight: J&J Monarch Robot Removes Kidney Stone With Mini-PCNL Procedure
Executive Summary
The company is sponsoring the first clinical study of robotically assisted electromagnetic-guided percutaneous access and mini-percutaneous nephrolithotomy – kidney stone removal – with the Monarch robotic-assisted platform for urology.
You may also be interested in...
FDA Clears J&J’s Ethicon Monarch Robotic System For Urology Procedures
J&J’s entry into the kidney stone management market will not threaten Boston Scientific’s leadership position in that market in the near-term, according to Wells Fargo analyst Larry Biegelsen.
Medtronic Earns CE Mark For Affera Ablation System, Touts New PFA Results
Results of the PULSED AF trial confirm that Medtronic’s PulseSelect pulsed field ablation is safe and effective for atrial fibrillation ablation. The company will likely incorporate PulseSelect into its Affera cardiac mapping and ablation system, which will soon be available in Europe.
News We’re Watching – FDA Nixes Neuralink Trials, Layoffs at J&J, Novel Knee Implants
This week, we learned that the US FDA thinks Elon Musk’s Neuralink brain interface device isn’t ready for human trials. Additionally, J&J cut about 300 medtech jobs, Stryker launched a knee implant, and Active Implants’ meniscus replacement device made it to the FDA’s advisory panel calendar.